Study of Immune-Related Liver Disease and Biological Samples
Part of Digestive system, Immune system & allergy clinical trials.
This is a research study collecting information and blood samples from patients with autoimmune hepatitis (a condition where the immune system attacks the liver) and patients with other types of liver disease. The goal is to better understand how these diseases develop and find new ways to diagnose and treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 10 years old (if you have autoimmune hepatitis) or at least 18 years old (if you have another liver disease)
- You weigh at least 25 kg (55 lbs) if you have autoimmune hepatitis, or at least 37 kg (82 lbs) if you have another liver disease
- You have been diagnosed with autoimmune hepatitis based on blood tests, antibody tests, or a liver biopsy
- You are able and willing to sign a consent form and allow your biological samples to be stored for research
- You do not have HIV, hepatitis B, or hepatitis C infections
- You are not under legal guardianship or curatorship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at specific immune cells (T cells) in the blood of people with autoimmune hepatitis (AIH) to better understand the disease. If you have untreated AIH and meet certain criteria, you may be able to participate.
This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.
This study examines the molecular profile of autoimmune hepatitis (a liver condition where the immune system attacks liver cells) using lipid analysis. Researchers hope to better understand the disease and potentially improve diagnosis and treatment in the future.
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
This study is building a database and collection of samples from people with autoimmune hepatitis in Italy. It aims to learn more about the disease and improve care.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
Hear when a new Autoimmune Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.